Press "Enter" to skip to content

New patent for Organon Usa drug IMPLANON

1
Copyright © DrugPatentWatch. Originally published at New patent for Organon Usa drug IMPLANON

Annual Drug Patent Expirations for IMPLANON
Annual Drug Patent Expirations for IMPLANON

Implanon is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has twenty-four patent family members in twenty-one countries.

The generic ingredient in IMPLANON is etonogestrel. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Organon Usa drug IMPLANON
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!